GB202212883D0 - Liquid or gelled pharmaceutical formulations of opicapone - Google Patents

Liquid or gelled pharmaceutical formulations of opicapone

Info

Publication number
GB202212883D0
GB202212883D0 GBGB2212883.9A GB202212883A GB202212883D0 GB 202212883 D0 GB202212883 D0 GB 202212883D0 GB 202212883 A GB202212883 A GB 202212883A GB 202212883 D0 GB202212883 D0 GB 202212883D0
Authority
GB
United Kingdom
Prior art keywords
opicapone
liquid
pharmaceutical formulations
gelled pharmaceutical
gelled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2212883.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bial Portela and Cia SA
Original Assignee
Bial Portela and Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial Portela and Cia SA filed Critical Bial Portela and Cia SA
Priority to GBGB2212883.9A priority Critical patent/GB202212883D0/en
Publication of GB202212883D0 publication Critical patent/GB202212883D0/en
Ceased legal-status Critical Current

Links

GBGB2212883.9A 2022-09-05 2022-09-05 Liquid or gelled pharmaceutical formulations of opicapone Ceased GB202212883D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2212883.9A GB202212883D0 (en) 2022-09-05 2022-09-05 Liquid or gelled pharmaceutical formulations of opicapone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2212883.9A GB202212883D0 (en) 2022-09-05 2022-09-05 Liquid or gelled pharmaceutical formulations of opicapone

Publications (1)

Publication Number Publication Date
GB202212883D0 true GB202212883D0 (en) 2022-10-19

Family

ID=83933185

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2212883.9A Ceased GB202212883D0 (en) 2022-09-05 2022-09-05 Liquid or gelled pharmaceutical formulations of opicapone

Country Status (1)

Country Link
GB (1) GB202212883D0 (en)

Similar Documents

Publication Publication Date Title
IL279464A (en) Pharmaceutical formulation of odevixibat
EP4146198A4 (en) Novel compositions of matter and pharmaceutical compositions
IL288375A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
PH12019502548A1 (en) Pyrazole magl inhibitors
SG11202012458RA (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP3600259A4 (en) Novel pharmaceutical formulations containing indirubin and derivatives thereof and methods of making and using the same
IL285141A (en) Liquid pharmaceutical formulations of pth conjugates
ZA202207188B (en) Liquid tasimelteon formulations and methods of use thereof
GB202313506D0 (en) Liquid or gelled pharmaceutical formulations of opicapone
GB202212883D0 (en) Liquid or gelled pharmaceutical formulations of opicapone
EP4119161A4 (en) Liquid pharmaceutical composition having improved stability
GB202002786D0 (en) Liquid pharmaceutical composition
GB202010230D0 (en) Pharmaceutical formulation
EP4021411A4 (en) Liquid pharmaceutical compositions of melatonin for oral and parenteral administration
GB202110420D0 (en) Liquid pharmaceutical composition of clonidine
GB201910294D0 (en) Liquid pharmaceutical composition for oral administration comprising paracetamol and codeine phosphate
IL285751A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
CA196849S (en) Dose cup for liquid medicinal formulations
IL285073A (en) Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same
IL286416A (en) Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof
GB202112511D0 (en) Liquid or gelled pharamaceutical formulations of opicapone
GB202207690D0 (en) Liquid pharmaceutical formulation of bisoprolol
EP4157262A4 (en) Pharmaceutical formulations of pilocarpine r-(+)-lipoate
EP3968955A4 (en) Pharmaceutical oral liquid solution of ivacaftor
GB202209022D0 (en) Pharmaceutical compositions and formulations for the treatment of retinoblastoma

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)